Research Funding

  • June 1, 2014 - May 31, 2019 - Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation, Co-Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: U01AI110658
  • April 1, 2012 - March 31, 2014 - "Donor-Specific Regulatory T Cell Therapy in Liver Transplantation", Co-Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: R34AI095135
  • April 1, 2007 - March 31, 2010 - Tolerance Induction Using Modified Dendritic Cells, Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: R03DK075431
  • April 1, 2003 - March 31, 2008 - Tolerance Induction Using Modified Dendritic Cells, Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: K08DK061970

Education

Cornell University, Ithaca, NY, B.A., 1986, Chemistry
Harvard Medical School, Boston, MA, MD, 1992, Magna Cum Laude
General Surgery Program, University of California at San Francisco, June 1992 to June 1999
University of California, San Francisco, CA, 7/99-3/01, Fellow in Transplant Surgery

Honors & Awards

  • 1986
    Phi Beta Kappa
  • 1986
    Merck Scholarship
  • 1985-87
    Beinecke Memorial National Scholar
  • 1987
    NIH Outstanding Summer Research Fellow Award
  • 1989
    Francis D. Moore Scholarship
  • 1991-92
    Howard Hughes Medical Institute Continuing Fellowship for "exceptional promise in biomedical research"
  • 1992
    Henry Asbury Christian Award for outstanding academic achievement
  • 1995
    British Journal of Surgery Award for outstanding surgical resident
  • 1995-97
    Howard Hughes Medical Institute Postdoctoral Fellowship Award
  • 1997
    ASTS Upjohn Award for most outstanding paper
  • 1997-98
    Hefne Research Grant
  • 1998
    Elected to AOA for excellence in teaching
  • 1999
    ASTS Travel Award
  • 1999-2001
    ASTS Novartis Fellowship in Transplantation
  • 2003-2005
    ASTS Faculty Development Award

Selected Publications

  1. Braun HJ, Torres AM, Louie F, Weinberg S, Kang SM, Ascher NL, Roberts JP Expanding Living Donor Liver Transplantation: Report of First United States Living Donor Liver Transplant Chain.  View on PubMed
  2. Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.  View on PubMed
  3. Yamanaga S, Freise CE, Stock PG, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Kang SM Inferior Long-Term Graft Survival of Suboptimal Kidneys After Living Donor Kidney Transplantation.  View on PubMed
  4. Gupta N, Henry RG, Kang SM, Strober J, Lim DA, Ryan T, Perry R, Farrell J, Ulman M, Rajalingam R, Gage A, Huhn SL, Barkovich AJ, Rowitch DH Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease.  View on PubMed
  5. Yamanaga S, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Stock PG, Kang SM Inferior long-term graft survival after end-to-side reconstruction for two renal arteries in living donor renal transplantation.  View on PubMed
  6. Yamanaga S, Posselt AM, Freise CE, Kobayashi T, Tavakol M, Kang SM A Single Perioperative Injection of Dexamethasone Decreases Nausea, Vomiting, and Pain after Laparoscopic Donor Nephrectomy.  View on PubMed
  7. Tang Q, Kang SM Interpretation of transplant biopsies and immune responses following Treg cell therapy.  View on PubMed
  8. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L, Mandelli ML, Ryan T, Perry R, Farrell J, Jeremy RJ, Ulman M, Huhn SL, Barkovich AJ, Rowitch DH Neural stem cell engraftment and myelination in the human brain.  View on PubMed
  9. Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.  View on PubMed
  10. Tang Q, Bluestone JA, Kang SM CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.  View on PubMed
  11. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL Expansion of a unique CD57?NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.  View on PubMed
  12. Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases.  View on PubMed
  13. Alemi F, Kwon E, Freise C, Kang SM, Hirose R, Stewart L, Corvera CU Hepatic surgery at a VA tertiary medical center: lessons learned.  View on PubMed
  14. Brennan TV, Hoang V, Garrod KR, Liu FC, Hayden T, Kim J, Kang SM A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.  View on PubMed
  15. Kim J, Chang CK, Hayden T, Liu FC, Benjamin J, Hamerman JA, Lanier LL, Kang SM The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection.  View on PubMed
  16. Kang SM Investigating the immunological mechanisms underlying organ transplant rejection.  View on PubMed
  17. Liu F, Kang SM Small bowel transplantation in mice.  View on PubMed
  18. Liu F, Kang SM Heterotopic heart transplantation in mice.  View on PubMed
  19. Garrod KR, Chang CK, Liu FC, Brennan TV, Foster RD, Kang SM Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival.  View on PubMed
  20. Melcher ML, Carter JT, Posselt A, Duh QY, Stoller M, Freise CE, Kang SM More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.  View on PubMed

Go to UCSF Profiles, powered by CTSI